Ganesh Kishore - Feb 2, 2022 Form 4 Insider Report for GreenLight Biosciences Holdings, PBC (GRNA)

Role
Director
Signature
/s/ David Kennedy, Attorney-in-fact
Stock symbol
GRNA
Transactions as of
Feb 2, 2022
Transactions value $
$750,000
Form type
4
Date filed
2/4/2022, 06:33 PM
Next filing
Aug 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GRNA Common Stock Award +5.74M 5.74M Feb 2, 2022 by MLS Capital Fund II, L.P. F1, F2
transaction GRNA Common Stock Purchase $750K +75K +1.31% $10.00* 5.82M Feb 2, 2022 by MLS Capital Fund II, L.P. F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued pursuant to the terms of a business combination agreement involving the issuer and GreenLight Biosciences, Inc. in exchange for capital stock previously issued by such company.
F2 Mr. Kishore, a director of the Issuer, is the Manager of MLS Capital fund II, L.P. and has the power to vote, or to direct the voting of, the shares held by MLS Capital fund II, L.P. By virtue of the foregoing, Mr. Kishore may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 of the Exchange Act) the shares held by MLS Capital fund II, L.P. Mr. Kishore disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein.
F3 Amount consists of 75,000 shares of common stock issued pursuant to a subscription agreement entered into between the Issuer and MLS Capital fund II, L.P.